Alpheus Medical raised $52M in Series B funding led by HealthQuest Capital and Samsara BioCapital to support a Phase 2B trial for glioblastoma treatment.
Alpheus Medical raised $52M in Series B funding led by HealthQuest Capital and Samsara BioCapital to support a Phase 2B trial for glioblastoma treatment.
05/15/25, 3:53 PM
Location
chanhassenMoney raised
$52 million
Industry
other
Round Type
series b
Investors
Sontag Innovation Fund, Brain Tumor Investment Fund, Bright Edge, Action Potential Venture Capita, Orbi Med, Samsara Bio Capital, Health Quest Capital
Alpheus Medical, a Chanhassen, MN-based clinical-stage oncology company, raised $52M in Series B funding. The round was led by HealthQuest Capital and Samsara BioCapital. The funds will support a Phase 2B trial for glioblastoma treatment. This innovative therapy selectively targets and destroys cancer cells using ultrasound.
Company Info
Location
1266 park road
chanhassen, minnesota, united states
Additional Info
Alpheus Medical, Inc, is a privately held company based in Oakdale, Minnesota, developing a novel sonodynamic therapy platform targeting solid body cancers. The company’s lead product utilizes a novel, non-invasive drug device combination for outpatient treatment of recurrent glioblastoma multiforme (rGBM). Alpheus Medical’s work has been developed in conjunction with some of the most accomplished names worldwide in neuro-oncology, and with support from the American Cancer Society and National Brain Tumor Society.